Sheaff Brock Investment Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-11,500
| Closed | -$43K | – | 546 |
|
|
2018
Q2 | $43K | Hold |
11,500
| – | – | ﹤0.01% | 506 |
|
|
2018
Q1 | $47K | Hold |
11,500
| – | – | ﹤0.01% | 508 |
|
|
2017
Q4 | $53K | Hold |
11,500
| – | – | 0.01% | 514 |
|
|
2017
Q3 | $82K | Hold |
11,500
| – | – | 0.01% | 543 |
|
|
2017
Q2 | $83K | Sell |
11,500
-1,500
| -12% | -$10.8K | 0.01% | 576 |
|
|
2017
Q1 | $80K | Buy |
13,000
+1,500
| +13% | +$9.23K | 0.01% | 570 |
|
|
2016
Q4 | $67K | Buy |
11,500
+1,500
| +15% | +$8.74K | 0.01% | 584 |
|
|
2016
Q3 | $53K | Hold |
10,000
| – | – | 0.01% | 537 |
|
|
2016
Q2 | $66K | Hold |
10,000
| – | – | 0.01% | 562 |
|
|
2016
Q1 | $47K | Hold |
10,000
| – | – | 0.01% | 587 |
|
|
2015
Q4 | $51K | Buy |
+10,000
| New | +$51K | 0.01% | 615 |
|